ESC 365 - Professor Lars Ryden

Speaker illustration

Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)

Member of:

Lars Rydén, Senior Professor of Cardiology at the Karolinska Institute, Sweden, specialised in internal medicine and cardiology. His research focus on arrhythmias, cardiac pacing, heart failure and diabetes-related cardiovascular disease. He published more than 700 artticles. He is Dr h.c. at Katowice University, Poland, and an honorary member of the Royal College of Physicians, UK and served as the President of the Swedish Cardiac Society and chaired the Scientific Board of the Swedish Heart Lung Foundation. He was the President of the European Society of Cardiology (ESC), and member of the board of World Heart Federation. He chaired numerous expert groups in collaboration with the ESC and European Commission and the group that produced the European Heart Health Charter and The Chronic Disease Alliance – A Unified Prevention Approach. Professor Rydén chaired the Task Forces of the 2007 and 2013 ESC/European Association for the Study of Diabetes (EASD) Guidelines for Diabetes.

Sessions Presentations Events Articles

It is better to invest in health than to pay for disease

Event: ESC Preventive Cardiology 2023

Topic: Epidemiology

Session type: Symposium

Improving cardiovascular risk in patients with obesity

Event: ESC Congress 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Diabetes and heart failure: a complex relationship

Event: ESC Congress 2019

Topic: Chronic Heart Failure

Session type: Symposium

Multi-dimensional glucagon-like peptide-1 receptor agonists — Positioning their role in treatment of type 2 diabetes and cardiovascular disease

Event: ESC Congress 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

The right glucose-lowering drugs for the right patient

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session type: Advances in Science

How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?

Event: ESC Congress 2018

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Session type: Symposium

Diabetes for the Cardiologist: integrated Cardio-Metabolic Care of Tomorrow

Event: ESC Congress 2018

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Session type: Symposium

Heart failure and diabetes: a treacherous combination

Event: ESC Congress 2017

Topic: Heart failure, other

Session type: Advances in Science

GLP-1 receptor agonists and cardiovascular risk management in type 2 diabetes: a new treatment paradigm?

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session type: Satellite Symposium

Treatment of type 2 diabetes - Important new aspects for the cardiologist

Event: ESC Congress 2017

Topic: Drug therapy

Session type: Symposium

ESC 365 is supported by